CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 141 enrolled
Drug / intervention
Stenting using Absolute Pro® and Pro LL® Peripheral Stent Systemsdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01444378
NCT01444378N/ACompleted

Absolute Pro® Peripheral Self-Expanding Stent System and the Absolute Pro® LL Peripheral Self-Expanding Stent Systems in the Treatment of Subjects With Atherosclerotic De Novo or Restenotic Lesions in the Native Superficial Femoral Artery and/or Native Proximal Popliteal Artery.

Abbott Medical Devices·interventional·Posted Sep 30, 2011·Updated Jun 6, 2017

In Brief

A clinical study evaluating Stenting using Absolute Pro® and Pro LL® Peripheral Stent Systems for Peripheral Artery Disease and Peripheral Vascular Disease. Completed, enrolled 141 participants across 1 site.

Detailed Summary

To evaluate the safety and effectiveness of the Absolute Pro® Peripheral Self-Expanding Stent System and the Absolute Pro® LL Peripheral Self-Expanding Stent System for the treatment of subjects with atherosclerotic de novo or restenotic lesions in the native superficial femoral artery (SFA) and/or the native proximal popliteal artery (PPA). CAUTION: Absolute Pro® Peripheral Self-Expanding Stent System and the Absolute Pro® LL Peripheral Self-Expanding Stent Systems are investigational devices. Limited by Federal (U.S.) law to investigational use only.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedSep 30, 2011
Enrollment StartOct 1, 2011
Primary CompletionDec 1, 2014
Study CompletionMay 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 14.8 years ago

Interventions

Stenting using Absolute Pro® and Pro LL® Peripheral Stent Systemsdevice

Stenting of the Superficial Femoral Artery (SFA) and/or proximal popliteal artery using either of these devices.